Ligand Pharmaceuticals Inc Reveals 14% Gain In Q4 Profit

(RTTNews) - Ligand Pharmaceuticals Inc (LGND) revealed earnings for its fourth quarter that gained ground from last year.

The company said its bottom line advanced to $14.26 million, or $0.66 per share. This was up from $12.46 million, or $0.60 per share, in last year's fourth quarter.

Analysts had expected the company to earn $0.65 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter fell 99.9% to $21.19 million. This was down from $23.00 billion last year.

Ligand Pharmaceuticals Inc earnings at a glance:

-Earnings (Q4): $14.26 Mln. vs. $12.46 Mln. last year. -Earnings Growth (Y-o-Y): 14.4% -EPS (Q4): $0.66 vs. $0.60 last year. -EPS Growth (Y-o-Y): 10.0% -Analysts Estimate: $0.65 -Revenue (Q4): $21.19 Mln vs. $23.00 Bln last year. -Revenue Change (Y-o-Y): -99.9%